• Is Immunocore Holdings (IMCR) Undervalued After Its Recent Share Price Rebound? Yahoo Finance Thu, 09 Jul 2026 15:11:45 GMT
• Immunocore Holdings (IMCR) Rebounds On Pipeline Optimism, Is The Stock Still Cheap? simplywall.st Thu, 09 Jul 2026 01:45:43 GMT
• Pre-Market Movement | Immunocore's Multifaceted News Sentiment Drives Stock Price Fluctuations 富途牛牛 Wed, 08 Jul 2026 13:34:21 GMT
• Immunocore stock holds its setup. Investors wait for the next verified trigger. AD HOC NEWS Tue, 07 Jul 2026 14:06:30 GMT
• Immunocore (IMCR) Stock May Trade Above Fair Value On A 48% Slump simplywall.st Sat, 04 Jul 2026 19:32:36 GMT
• Price to sales forward of Immunocore Holdings plc – NASDAQ:IMCR TradingView Tue, 30 Jun 2026 06:34:36 GMT
• Immunocore Holdings (IMCR) In Focus As Its Cash Backed Growth Narrative Shapes Valuation simplywall.st Mon, 29 Jun 2026 20:16:28 GMT
• Price to earnings forward of Immunocore Holdings plc – BOATS:IMCR TradingView Mon, 29 Jun 2026 12:39:10 GMT
• enterprise value to ebitda forward of immunocore holdings plc – nasdaq:imcr TradingView Mon, 29 Jun 2026 09:18:25 GMT
• immunocore holdings plc shs sponsored american depositary shares repr 1 sh actuals & estimates (nasdaq:imcr) TradingView Sat, 27 Jun 2026 08:53:32 GMT
• Price-Driven Insight from (IMCR) for Rule-Based Strategy Stock Traders Daily Sat, 27 Jun 2026 03:36:01 GMT
• imcr sec filings - immunocore holdings plc 10-k, 10-q, 8-k forms Stock Titan Fri, 26 Jun 2026 11:51:22 GMT
• Immunocore: KIMMTRAK Is Becoming A Cash Engine For A Much Larger TCR Platform Seeking Alpha Wed, 24 Jun 2026 07:00:00 GMT
• immunocore holdings plc (imcr) valuation: pe, pb & fair value analysis TradingKey Wed, 24 Jun 2026 07:00:00 GMT
• Is Immunocore Holdings (IMCR) One of the Best Small Cap Stocks to Buy for the Long Term? Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• How Investors May Respond To Immunocore (IMCR) Melanoma Data Highlighting Brenetafusp’s Potential In PD‑1‑Resistant Disease simplywall.st Mon, 22 Jun 2026 07:00:00 GMT
• Immunocore Holdings (IMCR) Stock Could Be 57% Below Fair Value After Recent Weakness Yahoo Finance Fri, 19 Jun 2026 07:00:00 GMT
• immunocore holdings (imcr) stock could be 57.1% undervalued after annual results simplywall.st Thu, 18 Jun 2026 21:54:10 GMT
• imcr sec filings - immunocore holdings plc 10-k, 10-q, 8-k forms Stock Titan Thu, 18 Jun 2026 19:33:21 GMT
• immunocore holdings plc (imcr) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:00:28 GMT
• Immunocore Holdings PLC (IMCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 20:55:06 GMT
• immunocore holdings plc (imcr) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 19:37:52 GMT
• immunocore holdings plc (imcr) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 17:27:42 GMT
• immunocore holdings plc (imcr) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 17:26:54 GMT
• immunocore holdings plc (imcr) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 17:20:08 GMT
• immunocore holdings plc (imcr) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 17:18:35 GMT
• Is it a Good Idea to Invest in Immunocore Stock Right Now? Zacks Investment Research Wed, 17 Jun 2026 07:00:00 GMT
• t. rowe price small-cap stock fund, inc.'s immunocore holdings plc(imcr) holding history GuruFocus Tue, 16 Jun 2026 09:24:31 GMT
• (IMCR) Price Dynamics and Execution-Aware Positioning Stock Traders Daily Tue, 16 Jun 2026 07:00:00 GMT
• immunocore holdings plc (imcr) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• immunocore holdings plc (imcr) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• immunocore holdings plc (imcr) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• immunocore holdings plc (imcr) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• The Bull Case For Immunocore Holdings (IMCR) Could Change Following New Brenetafusp Melanoma Data - Learn Why simplywall.st Wed, 10 Jun 2026 07:00:00 GMT
• IMCR Q1 2026 Earnings: Major EPS Beat as Immunocore Achieves Profitability - Debt Analysis Report dars.gov.et Tue, 09 Jun 2026 07:00:00 GMT
• jefferies raises immunocore stock price target on melanoma trial Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• (imcr) as a liquidity pulse for institutional tactics Stock Traders Daily Fri, 05 Jun 2026 00:54:02 GMT
• jefferies raises immunocore stock price target on melanoma trial Investing.com Thu, 04 Jun 2026 21:18:50 GMT
• h.c. wainwright maintains immunocore(imcr.us) with buy rating, maintains target price $100 Moomoo Thu, 04 Jun 2026 00:31:00 GMT
• immunocore reports 14.3-month survival in phase 1/2 trial of advanced melanoma drug candidate Moomoo Tue, 02 Jun 2026 09:03:47 GMT
• imcr stock price, quote & chart | immunocore holdings plc-adr (nasdaq:imcr) ChartMill Tue, 02 Jun 2026 07:00:00 GMT
• imcr financials: revenue breakdown, margins & competitor comparison Intellectia AI Tue, 02 Jun 2026 04:14:33 GMT
• agio halts tebapivat development in myelodysplastic syndromes TradingView Mon, 01 Jun 2026 13:43:00 GMT
• what immunocore holdings (imcr)'s phase 1 brenetafusp data and 160 mcg dose choice means for shareholders simplywall.st Mon, 01 Jun 2026 09:27:14 GMT
• Assessing Immunocore Holdings (IMCR) Valuation After New Brenetafusp Data At The 2026 ASCO Meeting Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• immunocore reports 14.3-month survival in phase 1/2 trial of advanced melanoma drug candidate Moomoo Mon, 01 Jun 2026 07:00:00 GMT
• immunocore (imcr) reports promising phase 1/2 trial results for brenetafusp GuruFocus Mon, 01 Jun 2026 00:22:30 GMT
• immunocore presents updated results from phase 1/2 trial of brenetafusp TipRanks Sun, 31 May 2026 21:38:46 GMT
• immunocore presents phase 1 data on brenetafusp for heavily pretreated advanced melanoma patients geneonline.com Sun, 31 May 2026 17:43:24 GMT
• Immunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma Yahoo Finance Sun, 31 May 2026 07:00:00 GMT
• Immunocore trial: brenetafusp 14.3-month survival in melanoma Stock Titan Sun, 31 May 2026 07:00:00 GMT
• Immunocore reports Phase 1 data for melanoma drug brenetafusp By Investing.com Investing.com Nigeria Sun, 31 May 2026 07:00:00 GMT
• immunocore reports promising phase 1 data for brenetafusp in heavily pretreated advanced melanoma at asco 2026 Quiver Quantitative Sun, 31 May 2026 07:00:00 GMT
• brenetafusp shows 87% 6-month survival in advanced melanoma, advancing phase 3 trial plans. Pluang Sun, 31 May 2026 07:00:00 GMT
• immunocore (imcr) director william pao receives grant of 27,492 options Stock Titan Thu, 28 May 2026 23:55:11 GMT
• immunocore (imcr) director granted 27,492 share options as award Stock Titan Thu, 28 May 2026 23:55:05 GMT
• immunocore holdings plc 8-k filing: company information, address, and exchange listing details (may 27, 2026) Minichart Thu, 28 May 2026 07:00:00 GMT
• immunocore (nasdaq: imcr) director awarded 27,492 share options Stock Titan Thu, 28 May 2026 07:00:00 GMT
• immunocore (imcr) director granted 27,492 options at $28.52 strike Stock Titan Thu, 28 May 2026 07:00:00 GMT
• immunocore (imcr) director kristine peterson receives 27,492 stock options at $28.52 Stock Titan Thu, 28 May 2026 07:00:00 GMT
• immunocore (nasdaq: imcr) investors back directors, pay and auditors at 2026 agm Stock Titan Wed, 27 May 2026 20:21:47 GMT
• immunocore limited announces termination of tina st leger from director role, effective may 26, 2026 marketscreener.com Wed, 27 May 2026 07:00:00 GMT
• wall street analysts think immunocore (imcr) could surge 111.53%: read this before placing a bet MSN Sun, 24 May 2026 11:32:05 GMT
• immunocore (imcr) q1 2026 earnings: stunning eps beat masks caution as shares slide 3.9% - earnings surprise score thelegaladvocate.com Sat, 23 May 2026 06:41:35 GMT
• Wall Street Analysts Think Immunocore (IMCR) Could Surge 111.53%: Read This Before Placing a Bet Yahoo Finance Fri, 22 May 2026 07:00:00 GMT
• h.c. wainwright maintains immunocore(imcr.us) with buy rating, maintains target price $100 Moomoo Fri, 22 May 2026 07:00:00 GMT
• immunocore holdings (nasdaq: imcr) plans 65,000 adr cashless sale Stock Titan Thu, 21 May 2026 07:00:00 GMT
• immunocore holdings stock (gb00bl963z95): insider share sale filing puts focus back on biotech’s g AD HOC NEWS Thu, 21 May 2026 07:00:00 GMT
• t-cell engagers market to record us$ 58.04 billion by 2035., openPR.com Tue, 19 May 2026 13:01:32 GMT
• how investors may respond to immunocore (imcr) q1 profitability and esop-linked share registration simplywall.st Tue, 19 May 2026 07:00:00 GMT
• a look at immunocore holdings (imcr) valuation after strong first quarter 2026 results simplywall.st Fri, 15 May 2026 11:36:52 GMT
• vestal point, ryan wilder disclose 2.77m ads stake in immunocore (imcr) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• t. rowe price (imcr) holds 1.89m adrs, files schedule 13g/a amendment Stock Titan Fri, 15 May 2026 07:00:00 GMT
• immunocore holdings stock (gb00bl963z95): recent price dip amid biotech trends AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• (imcr) movement as an input in quant signal sets Stock Traders Daily Wed, 13 May 2026 22:38:02 GMT
• mizuho cuts immunocore stock price target to $34 on trimmed revenue Investing.com Mon, 11 May 2026 07:00:00 GMT
• immunocore (imcr) is up 9.7% after strong q1 results and kimmtrak survival data release simplywall.st Mon, 11 May 2026 02:54:22 GMT
• immunocore holdings plc at td cowen healthcare conference transcript GuruFocus Sun, 10 May 2026 09:23:00 GMT
• immunocore (imcr) returns to quarterly profit and tests bearish profitability narratives Sahm Sat, 09 May 2026 17:41:19 GMT
• h.c. wainwright maintains immunocore(imcr.us) with buy rating, maintains target price $100 Moomoo Sat, 09 May 2026 15:27:00 GMT
• mizuho securities keeps their hold rating on immunocore holdings (imcr) The Globe and Mail Sat, 09 May 2026 07:00:00 GMT
• mizuho securities maintains immunocore(imcr.us) with hold rating, cuts target price to $34 富途牛牛 Fri, 08 May 2026 13:31:00 GMT
• goldman sachs maintains immunocore(imcr.us) with buy rating, raises target price to $73 富途牛牛 Fri, 08 May 2026 11:48:31 GMT
• h.c. wainwright maintains immunocore(imcr.us) with buy rating, maintains target price $100 Moomoo Fri, 08 May 2026 11:36:00 GMT
• immunocore (imcr) reports q1 2026 revenue slightly below expecta GuruFocus Fri, 08 May 2026 08:37:30 GMT
• uveal melanoma treatment market is expected to hit us$ 2.7 openPR.com Fri, 08 May 2026 07:29:06 GMT
• A Look At Immunocore (IMCR) Valuation After Strong Q1 2026 Results And New KIMMTRAK Survival Data Yahoo Finance Fri, 08 May 2026 07:00:00 GMT
• Immunocore (IMCR) Returns To Quarterly Profit And Tests Bearish Profitability Narratives simplywall.st Fri, 08 May 2026 07:00:00 GMT
• mizuho cuts price target on immunocore holdings to $34 from $38, keeps neutral rating marketscreener.com Fri, 08 May 2026 07:00:00 GMT
• wall street analysts are bullish on top healthcare picks The Globe and Mail Fri, 08 May 2026 07:00:00 GMT
• immunocore (imcr) reports q1 earnings with strong eps performanc GuruFocus Fri, 08 May 2026 03:45:00 GMT
• immunocore holdings: kimmtrak doubles likelihood of being alive at five years for patients with hla-a*02:01 positive metastatic uv... Moomoo Thu, 07 May 2026 22:50:18 GMT
• h.c. wainwright maintains immunocore(imcr.us) with buy rating, maintains target price $100 Moomoo Thu, 07 May 2026 17:33:00 GMT
• needham maintains immunocore(imcr.us) with buy rating, maintains target price $75 Moomoo Thu, 07 May 2026 17:13:27 GMT
• assessing immunocore holdings (imcr) valuation after q1 2026 results and new phase 3 survival data simplywall.st Thu, 07 May 2026 14:08:10 GMT
• goldman sachs maintains immunocore(imcr.us) with buy rating, raises target price to $73 Moomoo Thu, 07 May 2026 13:36:00 GMT
• immunocore (imcr) is up 10.1% after q1 profitability jumps on higher revenue and efficiency Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• immunocore q1 2026 results: kimmtrak sales grow 14% yoy, landmark 5-year survival data in uveal melanoma, and pipeline advancement... Minichart Thu, 07 May 2026 07:00:00 GMT
• immunocore holdings plc q1 2026 financial results: revenue, earnings, and forward-looking statements Minichart Thu, 07 May 2026 07:00:00 GMT
• imcr sec filings - immunocore holdings plc 10-k, 10-q, 8-k forms Stock Titan Thu, 07 May 2026 03:25:55 GMT
• needham maintains immunocore(imcr.us) with buy rating, maintains target price $75 富途牛牛 Wed, 06 May 2026 21:32:00 GMT
• immunocore holdings plc q1 2026 financial results: revenue, earnings, and forward-looking statements Minichart Wed, 06 May 2026 19:47:00 GMT
• immunocore q1 2026 results: kimmtrak sales grow 14% yoy, landmark 5-year survival data in uveal melanoma, and pipeline advancement... Minichart Wed, 06 May 2026 16:22:00 GMT
• immunocore holdings: kimmtrak doubles likelihood of being alive at five years for patients with hla-a*02:01 positive metastatic uv... Moomoo Wed, 06 May 2026 11:01:00 GMT
• Immunocore (IMCR) Is Up 10.1% After Q1 Profitability Jumps On Higher Revenue And Efficiency Yahoo Finance Wed, 06 May 2026 07:00:00 GMT
• Immunocore reports first quarter financial results and provides a business update Investing News Network Wed, 06 May 2026 07:00:00 GMT
• IMCR Financials: Income Statement, Balance Sheet & Cash Flow | Immunocore Holdings Plc Stock Titan Wed, 06 May 2026 07:00:00 GMT
• Immunocore Releases First Quarter Financial Results and Business Update geneonline.com Wed, 06 May 2026 07:00:00 GMT
• immunocore reports q1 net sales $106.7m, net income $13.0m and $845m liquidity TradingView Wed, 06 May 2026 07:00:00 GMT
• jefferies raises immunocore stock price target on melanoma trial Investing.com Wed, 06 May 2026 07:00:00 GMT
• earnings flash (imcr) immunocore holdings plc reports q1 revenue $106.7m marketscreener.com Wed, 06 May 2026 07:00:00 GMT
• immunocore drug doubles 5-year survival odds as sales hit $106.7m Stock Titan Wed, 06 May 2026 07:00:00 GMT
• immunocore holdings plc reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 06 May 2026 07:00:00 GMT
• immunocore (nasdaq: imcr) posts q1 2026 growth and major trial updates Stock Titan Wed, 06 May 2026 07:00:00 GMT
• immunocore (nasdaq: imcr) grows q1 2026 revenue and net income on kimmtrak Stock Titan Wed, 06 May 2026 07:00:00 GMT
• h.c. wainwright maintains immunocore(imcr.us) with buy rating, maintains target price $100 富途牛牛 Mon, 04 May 2026 22:24:53 GMT
• hussman strategic advisors inc. purchases shares of 42,000 immunocore holdings plc sponsored adr $imcr MarketBeat Mon, 04 May 2026 07:00:00 GMT
• immunocore (nasdaq:imcr) rating lowered to "strong sell" at zacks research MarketBeat Wed, 29 Apr 2026 11:53:17 GMT
• immunocore (imcr) to release quarterly earnings on wednesday MarketBeat Wed, 29 Apr 2026 10:54:08 GMT
• from cancer to infectious diseases: tcr therapies broaden immunotherapeutic horizons Technology Networks Wed, 29 Apr 2026 07:00:00 GMT
• how investors are reacting to immunocore (imcr) five-year kimmtrak survival data in uveal melanoma simplywall.st Wed, 29 Apr 2026 07:00:00 GMT
• assessing immunocore holdings (imcr) valuation after new five year kimmtrak survival data simplywall.st Sun, 26 Apr 2026 12:11:56 GMT
• immunocore holdings plc sponsored adr (nasdaq:imcr) receives consensus recommendation of "hold" from analysts MarketBeat Sat, 25 Apr 2026 07:00:00 GMT
• h.c. wainwright remains a buy on immunocore holdings (imcr) The Globe and Mail Fri, 24 Apr 2026 07:00:00 GMT
• h.c. wainwright maintains immunocore(imcr.us) with buy rating, maintains target price $100 Moomoo Thu, 23 Apr 2026 07:00:00 GMT
• q1 earnings forecast for immunocore issued by hc wainwright MarketBeat Wed, 22 Apr 2026 12:27:12 GMT
Immunocore Holdings plc(NASDAQ:IMCR) 
Immunocore Holdings plc, a late-stage biotechnology company, develops immunotherapies for the treatment of oncology, infectious, and autoimmune diseases. The company's lead oncology therapeutic candidate is tebentafusp, which is in a randomized Phase 3 clinical trial in patients with previously untr...
Share this website to your friends